Company Name : Glaxo Smith Kline ISIN Code : EGS38171C012 Reuters Code : BIOC.CA Content : The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2021 according to Article 30 of the Listing Rules. the Disclosure Form (1,403 KB) the Disclosure Form (1,403 KB)